A recent study from the UK has unveiled a startling truth: individuals who discontinue the use of modern weight-loss medications regain weight at an alarming rate—four times quicker than those who stop following traditional diet and exercise plans. This finding, released on January 8, has significant implications for how we understand weight management following the use of these drugs.
The rapid weight regain is largely attributed to the extensive initial weight loss that users experience while on these medications, according to the British researchers who conducted a comprehensive review of existing studies. The new class of appetite-suppressing injectable medications known as GLP-1 agonists has surged in popularity over recent years, providing a groundbreaking approach to treating obesity and diabetes across various nations.
These medications have demonstrated effectiveness in helping users shed between 15% to 20% of their body weight, which is quite impressive. Dr. Susan Jebb, a public health nutrition scientist at Oxford University and one of the study's authors, remarked, "This all appears to be a good news story." However, she also pointed out a concerning trend: approximately half of the individuals prescribed these medications stop taking them within a year. Common side effects, such as nausea, and the high cost—exceeding $1,000 (approximately S$1,283) per month in the United States—are likely reasons for this discontinuation.
In their analysis, the researchers examined 37 different studies focusing on the cessation of various weight-loss drugs. They discovered that, on average, participants regained about 0.4 kg each month after quitting the medications. Notably, six of these clinical trials investigated the effects of semaglutide (the active ingredient in Novo Nordisk's Ozempic and Wegovy) and tirzepatide (featured in Eli Lilly’s Mounjaro and Zepbound). Participants using these medications experienced an average weight reduction of nearly 15 kg, but shockingly, they regained 10 kg within a year after stopping treatment—the longest duration of follow-up available for these relatively new drugs.
The projections indicated that participants could return to their initial weight within about 18 months, with measurements related to heart health, including blood pressure and cholesterol, reverting to original levels after roughly 1.4 years. In contrast, individuals engaged in programs based solely on diet and exercise lost considerably less weight, but it took them an average of four years to regain the pounds they had shed. This stark difference highlights that those who used weight-loss drugs experienced weight regain at a rate four times faster.
Lead study author Sam West from Oxford University elaborated, "Greater weight loss tends to result in faster weight regain." Additionally, a separate analysis revealed that the phenomenon of accelerated weight gain occurred consistently after medication use, independent of the initial weight lost. This might suggest that individuals who adopt healthier eating habits and increase their physical activity may continue these practices even as they begin to regain some weight.
Dr. Jebb stressed the importance of recognizing GLP-1 medications as valuable assets in the fight against obesity, stating, "Obesity is a chronic relapsing condition." She suggested that ongoing treatment would likely need to be lifelong, similar to management practices for conditions like hypertension. This insight could significantly influence how national health systems evaluate the cost-effectiveness of these drugs.
Associate Professor Garron Dodd, a metabolic neuroscience researcher at the University of Melbourne who was not part of the study, emphasized that this data underscores the notion that these medications should be viewed as a starting point rather than a definitive cure. He stated, "Sustainable treatment will likely require combination approaches, longer-term strategies, and therapies aimed at altering how the brain perceives energy balance, not just focusing on caloric intake."
What do you think about the findings of this study? Do you believe that long-term medication use is necessary for effective weight management? Join the conversation in the comments below!
